APA (7th ed.) Citation

GA, L., A, R., S, D., EB, S., SG, W., C, C., . . . CA, M. (2022). Characteristics Associated With Growth Differentiation Factor 15 in Heart Failure With Preserved Ejection Fraction and the Impact of Pirfenidone. Journal of the American Heart Association, 11(14), e024668. https://doi.org/10.1161/JAHA.121.024668

Chicago Style (17th ed.) Citation

GA, Lewis, Rosala-Hallas A, Dodd S, Schelbert EB, Williams SG, Cunnington C, McDonagh T, and Miller CA. "Characteristics Associated With Growth Differentiation Factor 15 in Heart Failure With Preserved Ejection Fraction and the Impact of Pirfenidone." Journal of the American Heart Association 11, no. 14 (2022): e024668. https://doi.org/10.1161/JAHA.121.024668.

MLA (9th ed.) Citation

GA, Lewis, et al. "Characteristics Associated With Growth Differentiation Factor 15 in Heart Failure With Preserved Ejection Fraction and the Impact of Pirfenidone." Journal of the American Heart Association, vol. 11, no. 14, 2022, p. e024668, https://doi.org/10.1161/JAHA.121.024668.